Exfoliative dermatitis due ot carbamazepine (tegretol).
D002220:Carbamazepine / Q000009:adverse effects; D002509:Cephaloridine / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D003984:Dibenzazepines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects; D011241:Prednisone / Q000627:therapeutic use
D003984:Dibenzazepines; D002220:Carbamazepine; D010672:Phenytoin; D002509:Cephaloridine; D011241:Prednisone